Tagscherer, K E <br/><br/>
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.  [electronic resource] 

 -  Oncogene  Nov 2008 
 - 6646-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2008.259  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Biphenyl Compounds--pharmacology<br/>Cell Line, Tumor<br/>Glioblastoma--genetics<br/>Humans<br/>Mice<br/>Neoplastic Stem Cells--cytology<br/>Nitrophenols--pharmacology<br/>Piperazines--pharmacology<br/>Protein Binding<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Sulfonamides--pharmacology<br/>Survival Rate<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>Xenograft Model Antitumor Assays